
Germany backs EU recovery fund, Gilead drug flops, Rana Foroohar on US austerity
FT News Briefing
00:00
Market Reactions and Early Trial Results for Remdesivir
This chapter explores the accidental publication of early trial results for remdesivir by the World Health Organization and the implications of these findings. It discusses the mixed reactions from Gilead and the stock market, reflecting the heightened sensitivity to the drug's perceived effectiveness.
Play episode from 03:07
Transcript


